Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dave Singh

Showing results (481-490 of 505) with videos related to

Pageof 51
Sort By:
Ebiomedicine|July 11, 2026
Clinical phenotyping of asthma patients with elevated sputum eosinophils and low blood eosinophils: a post-hoc analysis of the multicentre ATLANTIS cohortPauline J M Kuks, Atheer M A Aabed, Lauren C A Premereur, et al.
American Journal of Respiratory and Critical Care Medicine|January 28, 2017
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive SummaryClaus F Vogelmeier, Gerard J Criner, Fernando J Martinez, et al.
Respirology (Carlton, Vic.)|February 3, 2017
Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive SummaryClaus F Vogelmeier, Gerard J Criner, Fernando J Martinez, et al.
The Lancet. Microbe|May 11, 2022
Lung microbiome composition and bronchial epithelial gene expression in patients with COPD versus healthy individuals: a bacterial 16S rRNA gene sequencing and host transcriptomic analysisMohammadali Yavari Ramsheh, Koirobi Haldar, Anna Esteve-Codina, et al.
American Journal of Respiratory and Critical Care Medicine|March 17, 2018
Opsonic Phagocytosis in Chronic Obstructive Pulmonary Disease Is Enhanced by Nrf2 AgonistsMartin A Bewley, Richard C Budd, Eilise Ryan, et al.
The Journal of Allergy and Clinical Immunology|July 24, 2017
Toll-like receptor 3 blockade in rhinovirus-induced experimental asthma exacerbations: A randomized controlled studyPhilip E Silkoff, Susan Flavin, Robert Gordon, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|November 6, 2020
InforMing the PAthway of COPD Treatment (IMPACT Trial) Single-Inhaler Triple Therapy (Fluticasone Furoate/Umeclidinium/Vilanterol) Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients With COPD: Analysis of the Western Europe and North America RegionsArnaud Bourdin, Gerard Criner, Gilles Devouassoux, et al.
ERJ Open Research|February 18, 2025
Neutrophilic inflammation in sputum or blood does not define a clinically distinct asthma phenotype in ATLANTISPauline J M Kuks, Tessa M Kole, Monica Kraft, et al.
Scientific Reports|December 29, 2019
High degree of polyclonality hinders somatic mutation calling in lung brush samples of COPD cases and controlsGian-Andri Thun, Sophia Derdak, Francesc Castro-Giner, et al.
The Journal of Allergy and Clinical Immunology|January 4, 2026
Nasal gene expression shows a distinct signature in T2-high asthma but not in T2-low diseaseTatiana Karp, Simon Kebede Merid, Nazanin Zounemat Kermani, et al.
Pageof 51

Showing results (481-490 of 505) with videos related to

Sort By:
Pageof 51
Ebiomedicine|July 11, 2026
Clinical phenotyping of asthma patients with elevated sputum eosinophils and low blood eosinophils: a post-hoc analysis of the multicentre ATLANTIS cohortPauline J M Kuks, Atheer M A Aabed, Lauren C A Premereur, et al.
American Journal of Respiratory and Critical Care Medicine|January 28, 2017
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive SummaryClaus F Vogelmeier, Gerard J Criner, Fernando J Martinez, et al.
Respirology (Carlton, Vic.)|February 3, 2017
Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive SummaryClaus F Vogelmeier, Gerard J Criner, Fernando J Martinez, et al.
The Lancet. Microbe|May 11, 2022
Lung microbiome composition and bronchial epithelial gene expression in patients with COPD versus healthy individuals: a bacterial 16S rRNA gene sequencing and host transcriptomic analysisMohammadali Yavari Ramsheh, Koirobi Haldar, Anna Esteve-Codina, et al.
American Journal of Respiratory and Critical Care Medicine|March 17, 2018
Opsonic Phagocytosis in Chronic Obstructive Pulmonary Disease Is Enhanced by Nrf2 AgonistsMartin A Bewley, Richard C Budd, Eilise Ryan, et al.
The Journal of Allergy and Clinical Immunology|July 24, 2017
Toll-like receptor 3 blockade in rhinovirus-induced experimental asthma exacerbations: A randomized controlled studyPhilip E Silkoff, Susan Flavin, Robert Gordon, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|November 6, 2020
InforMing the PAthway of COPD Treatment (IMPACT Trial) Single-Inhaler Triple Therapy (Fluticasone Furoate/Umeclidinium/Vilanterol) Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients With COPD: Analysis of the Western Europe and North America RegionsArnaud Bourdin, Gerard Criner, Gilles Devouassoux, et al.
ERJ Open Research|February 18, 2025
Neutrophilic inflammation in sputum or blood does not define a clinically distinct asthma phenotype in ATLANTISPauline J M Kuks, Tessa M Kole, Monica Kraft, et al.
Scientific Reports|December 29, 2019
High degree of polyclonality hinders somatic mutation calling in lung brush samples of COPD cases and controlsGian-Andri Thun, Sophia Derdak, Francesc Castro-Giner, et al.
The Journal of Allergy and Clinical Immunology|January 4, 2026
Nasal gene expression shows a distinct signature in T2-high asthma but not in T2-low diseaseTatiana Karp, Simon Kebede Merid, Nazanin Zounemat Kermani, et al.
Pageof 51